Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Publication year range
1.
Genet Mol Res ; 14(3): 10877-87, 2015 Sep 10.
Article in English | MEDLINE | ID: mdl-26400315

ABSTRACT

Prostaglandin E2 (dinoprostone) is largely used for labor induction. However, one-third of patients do not respond to treatment. One cause of this poor response may be associated with changes in regulation of prostaglandin E receptors (EP1-4). In this study, we investigated EP mRNA expression in the uterine cervix and lower uterine segment myometrium for term births. Biopsies were obtained from women with successful (responders) and failed (non-responders) dinoprostone labor induction, while women that underwent spontaneous labor were included as controls. EP1 mRNA was upregulated in the cervical tissue of women who did not respond to dinoprostone induction. In addition, in the myometrium, significantly higher levels of EP3 mRNA were observed in women treated with dinoprostone, independent of their responsiveness. Dinoprostone-responders presented 3.6-fold higher levels of EP3 mRNA expression than the spontaneous labor group. Significantly higher levels of EP3 mRNA in the myometrium of the dinoprostone-treated group indicated that dinoprostone may regulate the EP3 gene on the transcriptional level. These results highlight the relationship between EP gene expression and delivery and indicate that understanding the regulation of prostaglandin E receptors may lead to improved labor induction.


Subject(s)
Dinoprostone/therapeutic use , Labor, Induced/methods , RNA, Messenger/biosynthesis , Receptors, Prostaglandin E, EP1 Subtype/genetics , Uterine Contraction/drug effects , Adult , Case-Control Studies , Cervix Uteri/drug effects , Cervix Uteri/metabolism , Female , Gene Expression/drug effects , Humans , Myometrium/drug effects , Myometrium/metabolism , Pregnancy , RNA, Messenger/genetics , Receptors, Prostaglandin E, EP1 Subtype/biosynthesis , Receptors, Prostaglandin E, EP2 Subtype/biosynthesis , Receptors, Prostaglandin E, EP2 Subtype/genetics , Receptors, Prostaglandin E, EP3 Subtype/biosynthesis , Receptors, Prostaglandin E, EP3 Subtype/genetics , Treatment Failure
2.
Vet Pathol ; 49(6): 930-40, 2012 Nov.
Article in English | MEDLINE | ID: mdl-22362966

ABSTRACT

Persistent infection (PI) with bovine viral diarrhea virus (BVDV) has been associated with osteopetrosis and other long bone lesions, most commonly characterized as transverse zones of unmodeled metaphyseal trabeculae in fetuses and calves. This study was undertaken to characterize the morphogenesis of fetal long bone lesions. Forty-six BVDV-naïve pregnant Hereford heifers of approximately 18 months of age were inoculated with noncytopathic BVDV type 2 containing media or media alone on day 75 of gestation to produce PI and control fetuses, respectively, which were collected via cesarean section on days 82, 89, 97, 192, and 245 of gestation. Radiographic and histomorphometric abnormalities were first detected on day 192, at which age PI fetal long bone metaphyses contained focal densities (4 of 7 fetuses) and multiple alternating transverse radiodense bands (3 of 7 fetuses). Day 245 fetuses were similarly affected. Histomorphometric analysis of proximal tibial metaphyses from day 192 fetuses revealed transverse zones with increased calcified cartilage core (Cg.V/BV, %) and trabecular bone (BV/TV, %) volumes in regions corresponding to radiodense bands (P < .05). Numbers of tartrate resistant acid phosphatase positive osteoclasts (N.Oc/BS, #/mm(2)) and bone perimeter occupied (Oc.S/BS, %) were both decreased (P < .05). Mineralizing surface (MS/BS, %), a measure of tissue level bone formation activity, was reduced in PI fetuses (P < .05). It is concluded that PI with BVDV induces cyclic abnormal trabecular modeling, which is secondary to reduced numbers of osteoclasts. The factors responsible for these temporal changes are unknown but may be related to the time required for osteoclast differentiation from precursor cells.


Subject(s)
Bovine Virus Diarrhea-Mucosal Disease/pathology , Diarrhea Virus 2, Bovine Viral/isolation & purification , Infectious Disease Transmission, Vertical/veterinary , Osteopetrosis/veterinary , Pregnancy Complications, Infectious/veterinary , Animals , Antibodies, Viral , Bovine Virus Diarrhea-Mucosal Disease/diagnostic imaging , Bovine Virus Diarrhea-Mucosal Disease/virology , Cattle , Diarrhea Virus 2, Bovine Viral/genetics , Diarrhea Virus 2, Bovine Viral/immunology , Female , Femur/diagnostic imaging , Femur/pathology , Fetus/pathology , Fetus/virology , Male , Osteoclasts , Osteogenesis , Osteopetrosis/diagnostic imaging , Osteopetrosis/pathology , Osteopetrosis/virology , Pregnancy , Pregnancy Complications, Infectious/pathology , Pregnancy Complications, Infectious/virology , RNA, Viral/genetics , Radiography , Tibia/diagnostic imaging , Tibia/pathology
3.
Soc Reprod Fertil Suppl ; 67: 325-40, 2010.
Article in English | MEDLINE | ID: mdl-21755682

ABSTRACT

The ovine conceptus releases interferon-tau (IFNT), which prevents upregulation of the endometrial estrogen receptor (ESR1) and, consequently, oxytocin receptor (OXTR), thereby disrupting pulsatile release of prostaglandin F2alpha (PGF) in response to oxytocin. IFNT, through paracrine action on the endometrium, protects the corpus luteum (CL) during maternal recognition of pregnancy. Pregnancy also induces IFN stimulated genes (ISGs) in peripheral blood mononuclear cells (PBMCs), which is interpreted to reflect a "prompted" antiviral and immune cell response peripherally in ruminants. IFNT was recently demonstrated to be released from the uterus in amounts of 200 microg (2 x 10(7) U)/24 h via the uterine vein and to induce ISGs in the CL during maternal recognition of pregnancy. Delivery of recombinant ovine (ro) IFNT into the uterine vein in a location that is upstream of the utero-ovarian plexus from Day 10 to 17 maintained serum progesterone concentrations and extended normal 16-17 d estrous cycles to beyond 32 d. It is concluded from these studies that IFNT is released into the uterine vein and initiates a peripheral antiviral response to protect pregnancy from maternal viral infection. It also may have endocrine action through inducing luteal resistance to PGF and longer-term survival of the CL and maintenance of pregnancy.


Subject(s)
Interferon Type I/metabolism , Luteolysis/physiology , Pregnancy Proteins/metabolism , Sheep/physiology , Animals , Estrus/physiology , Female , Pregnancy , Prostaglandins/metabolism , Prostaglandins/pharmacology , Time Factors
4.
Phys Rev E Stat Nonlin Soft Matter Phys ; 71(6 Pt 2): 066504, 2005 Jun.
Article in English | MEDLINE | ID: mdl-16089888

ABSTRACT

The ultimate performance of a storage-ring free-electron laser in terms of light stability and extracted power depends on the possibility of simultaneously controlling the electron-beam and laser dynamics. As a preliminary requirement, the level of longitudinal and transverse electron-beam stability must be high enough to guarantee the laser start-up and growth. This is usually obtained by means of dedicated feedback systems. Once such a requirement is satisfied, the possibility of establishing and maintaining a continuous-wave operation mode finally resides in a deep understanding of the strongly coupled laser-electrons dynamics. For this purpose, we have developed a simple theoretical model which has been proved to be able to provide insight into the evolution of the laser intensity. In this framework, we have also proposed the possibility of utilizing a derivative closed-loop feedback to create or enlarge the region of stable signal. A feedback of this type has been implemented on the Elettra storage-ring free-electron laser. The obtained results, which fully confirm our predictions, are discussed in this paper.

5.
Cephalalgia ; 23(2): 146-9, 2003 Mar.
Article in English | MEDLINE | ID: mdl-12603372

ABSTRACT

The International Headache Society (IHS) criteria for headache related to haemodialysis consider that the headaches must begin during haemodialysis and terminate within 24 h. Twenty-eight patients whose headaches started by the time they entered the dialysis programme were prospectively studied. We were not able to classify eight patients that presented the headaches between the sessions. Despite the small number of patients in our study being too low to provide a basis for change in the IHS classification, it serves as an observational report demonstrating possible varieties of headache related to haemodialysis.


Subject(s)
Headache/classification , Headache/etiology , Practice Guidelines as Topic/standards , Renal Dialysis/adverse effects , Adult , Female , Headache/diagnosis , Humans , International Cooperation , Male , Predictive Value of Tests , Renal Insufficiency/complications , Renal Insufficiency/therapy , Reproducibility of Results , Societies, Medical
SELECTION OF CITATIONS
SEARCH DETAIL
...